Literature DB >> 11194719

Mastitis, polyarthritis and abortion caused by Mycoplasma species bovine group 7 in dairy cattle.

S Hum1, A Kessell, S Djordjevic, R Rheinberger, M Hornitzky, W Forbes, J Gonsalves.   

Abstract

OBJECTIVE: To report an outbreak of mastitis, polyarthritis and abortion caused by Mycoplasma sp bovine group 7 in three large, centrally-managed dairies and to review the relevant literature.
DESIGN: Epidemiological, clinical and laboratory data were analysed, collated and reported. Multidisciplinary procedures were employed. These included clinical assessment and comprehensive laboratory investigations of affected calves, aborted foetuses and milk samples. Mycoplasma cultures and genetic analyses of isolates were undertaken to identify the aetiological agent.
RESULTS: About 30% of 240 calves usually kept in a calf rearing facility developed severe polyarthritis as a result of Mycoplasma sp bovine group 7 infection between 2 and 3 weeks of age. Multiple abortions occurred on these farms. Mycoplasma sp bovine group 7 was recovered from the fibrinopurulent synovial exudates of four 14-day-old calves, from the stomach contents and lungs of two aborted foetuses, from 14 of 21 bulk milk and four of 10 mastitic quarters. Three bulk colostrum samples cultured during the outbreak were negative for mycoplasma.
CONCLUSION: Mycoplasma sp bovine group 7 caused significant economic losses as a result of polyarthritis, abortion and mastitis. The disease probably originated from udder infections with spread being facilitated by the decreased use of tetracycline in the treatment of mastitis. Neonatal calves were most likely infected by the consumption of milk contaminated with the organism. Abortions presumably resulted from mycoplasmaemia. This appears to be the first report in Australia of bovine abortion resulting from Mycoplasma sp infection.

Entities:  

Mesh:

Year:  2000        PMID: 11194719     DOI: 10.1111/j.1751-0813.2000.tb10444.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  8 in total

1.  Cell surface antigens of Mycoplasma species bovine group 7 bind to and activate plasminogen.

Authors:  Kylie Bower; Steven P Djordjevic; Nicholas M Andronicos; Marie Ranson
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Vaginal bacterial community composition and concentrations of estradiol at the time of artificial insemination in Brangus heifers.

Authors:  Riley D Messman; Zully E Contreras-Correa; Henry A Paz; George Perry; Caleb O Lemley
Journal:  J Anim Sci       Date:  2020-06-01       Impact factor: 3.159

3.  Mycoplasma leachii sp. nov. in calves, China.

Authors:  Ji-Tao Chang; Hai-Jun Liu; Li Yu
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

4.  Cloning and expression of P67 protein of Mycoplasma leachii.

Authors:  Sabarinath Thankappan; Rajneesh Rana; Arun Thachappully Remesh; Valsala Rekha; Viswas Konasagara Nagaleekar; Bhavani Puvvala
Journal:  Vet World       Date:  2017-09-21

5.  Prevalence of Mycoplasma bovis Infection in Calves and Dairy Cows in Western Australia.

Authors:  Jully Gogoi-Tiwari; Harish Kumar Tiwari; Nadeeka K Wawegama; Chintha Premachandra; Ian Duncan Robertson; Andrew David Fisher; Frank Karanja Waichigio; Pete Irons; Joshua W Aleri
Journal:  Vet Sci       Date:  2022-07-11

Review 6.  Review of Diagnostic Procedures and Approaches to Infectious Causes of Reproductive Failures of Cattle in Australia and New Zealand.

Authors:  Michael P Reichel; Lloyd C Wahl; Fraser I Hill
Journal:  Front Vet Sci       Date:  2018-10-02

7.  Coronavirus infection in intensively managed cattle with respiratory disease.

Authors:  P M Hick; A J Read; I Lugton; F Busfield; K E Dawood; L Gabor; M Hornitzky; P D Kirkland
Journal:  Aust Vet J       Date:  2012-08-16       Impact factor: 1.281

Review 8.  Biosecurity and bovine respiratory disease.

Authors:  Robert J Callan; Franklyn B Garry
Journal:  Vet Clin North Am Food Anim Pract       Date:  2002-03       Impact factor: 3.357

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.